{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:23:16Z","timestamp":1789147396037,"version":"build-2803163510"},"reference-count":113,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>Gut dysbiosis, characterized by an imbalance in the gut microbiota, has emerged as a potential factor influencing CKD progression. This condition plays a crucial role in the gut-kidney axis, where changes in microbial composition can contribute to systemic inflammation and uremic toxin production and ultimately exacerbate kidney damage. Understanding the dynamics of the gut-kidney axis provides new insights into potential therapeutic strategies to mitigate CKD progression. Diet is the primary driver of gut microbiota composition. Therefore, an approach emphasizing healthy nutritional patterns is recommended for improving overall health, cardiovascular disease, and profoundly altered metabolic patterns in patients with CKD. Dietary modifications have been explored as therapeutic strategies targeting the microbiome to improve outcomes in CKD. An emerging therapeutic target is the production of dysmetabolites by the gut microbiota, which may help alleviate uremic and cardiovascular toxicity. In addition, future research should broaden the scope to include other microorganisms, such as fungi, archaea, and viruses. This expanded focus will enable a more comprehensive understanding of the gut-kidney axis and pave the way for more personalized and effective treatment strategies for patients with CKD. This review explores the role of lifestyle, particularly diet, in kidney health; highlights new gut microbiome therapies; and identifies research opportunities in CKD.<\/jats:p>","DOI":"10.2215\/cjn.0000000705","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T12:03:20Z","timestamp":1741694600000},"page":"1003-1013","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Dietary Intake and Gut Microbiome in CKD"],"prefix":"10.2215","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6739-8832","authenticated-orcid":false,"given":"Julie Ann","family":"Kemp","sequence":"first","affiliation":[{"name":"Graduate Program in Nutrition Sciences, Fluminense Federal University (UFF), Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4957-3630","authenticated-orcid":false,"given":"Marcia","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Graduate Program in Biological Sciences \u2013 Physiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0898-5118","authenticated-orcid":false,"given":"Nat\u00e1lia A.","family":"Borges","sequence":"additional","affiliation":[{"name":"Graduate Program in Food, Nutrition and Health \u2013 Institute of Nutrition, State University of Rio de Janeiro (UERJ), Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8507-2369","authenticated-orcid":false,"given":"Ludmila F.M.F.","family":"Cardozo","sequence":"additional","affiliation":[{"name":"Graduate Program in Nutrition Sciences, Fluminense Federal University (UFF), Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9707-7199","authenticated-orcid":false,"given":"Denis","family":"Fouque","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, INSERM 1060, CENS, Universit\u00e9 Claude Bernard Lyon 1, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6752-6056","authenticated-orcid":false,"given":"Denise","family":"Mafra","sequence":"additional","affiliation":[{"name":"Graduate Program in Nutrition Sciences, Fluminense Federal University (UFF), Rio de Janeiro, Brazil"},{"name":"Graduate Program in Biological Sciences \u2013 Physiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"issue":"2","key":"B1-20250919","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41440-018-0144-z","article-title":"Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease","volume":"42","author":"Onal","year":"2019","journal-title":"Hypertens Res."},{"key":"B2-20250919","doi-asserted-by":"crossref","first-page":"837500","DOI":"10.3389\/fphar.2022.837500","article-title":"The intestinal microbiota and metabolites in the gut-kidney-heart Axis of chronic kidney disease","volume":"13","author":"Huang","year":"2022","journal-title":"Front Pharmacol."},{"issue":"6","key":"B3-20250919","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00467-016-3392-7","article-title":"Gut microbiome and kidney disease: a bidirectional relationship","volume":"32","author":"Al Khodor","year":"2017","journal-title":"Pediatr Nephrol."},{"key":"B4-20250919","doi-asserted-by":"crossref","first-page":"122863","DOI":"10.1016\/j.lfs.2024.122863","article-title":"Gut microbiota dynamics and association with chronic kidney disease: a longitudinal study within the PREDIMED-Plus trial","volume":"351","author":"Atzeni","year":"2024","journal-title":"Life Sci."},{"issue":"5","key":"B5-20250919","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ki.2015.255","article-title":"Probiotics and chronic kidney disease","volume":"88","author":"Koppe","year":"2015","journal-title":"Kidney Int."},{"issue":"12","key":"B6-20250919","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3390\/microorganisms8121862","article-title":"Chronic kidney disease, gut dysbiosis, and constipation: a burdensome triplet","volume":"8","author":"Ikee","year":"2020","journal-title":"Microorganisms."},{"issue":"6S","key":"B7-20250919","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1053\/j.jrn.2022.12.004","article-title":"Targeting the gut microbiota in kidney disease: the future in renal nutrition and metabolism","volume":"33","author":"Lambert","year":"2023","journal-title":"J Ren Nutr."},{"key":"B8-20250919","doi-asserted-by":"crossref","first-page":"790783","DOI":"10.3389\/fmed.2021.790783","article-title":"The human microbiome in chronic kidney disease: a double-edged sword","volume":"8","author":"Wehedy","year":"2021","journal-title":"Front Med (Lausanne)."},{"key":"B9-20250919","doi-asserted-by":"crossref","first-page":"843695","DOI":"10.3389\/fimmu.2022.843695","article-title":"Gut mycobiome in patients with chronic kidney disease was altered and associated with immunological profiles","volume":"13","author":"Hu","year":"2022","journal-title":"Front Immunol."},{"key":"B10-20250919","doi-asserted-by":"crossref","first-page":"1317809","DOI":"10.3389\/fimmu.2023.1317809","article-title":"Exploring the gut mycobiome: differential composition and clinical associations in hypertension, chronic kidney disease, and their comorbidity","volume":"14","author":"Qiu","year":"2023","journal-title":"Front Immunol."},{"issue":"4","key":"B11-20250919","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.3390\/ijms24043897","article-title":"The human virome and its crosslink with glomerulonephritis and IgA nephropathy","volume":"24","author":"Sallustio","year":"2023","journal-title":"Int J Mol Sci."},{"issue":"1","key":"B12-20250919","doi-asserted-by":"crossref","first-page":"2226925","DOI":"10.1080\/19490976.2023.2226925","article-title":"Alterations in the gut virome are associated with type 2 diabetes and diabetic nephropathy","volume":"15","author":"Fan","year":"2023","journal-title":"Gut Microbes."},{"key":"B13-20250919","doi-asserted-by":"crossref","first-page":"102629","DOI":"10.1016\/j.anaerobe.2022.102629","article-title":"Archaea from the gut microbiota of humans: could be linked to chronic diseases?","volume":"77","author":"Mafra","year":"2022","journal-title":"Anaerobe."},{"issue":"1-3","key":"B14-20250919","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000181424","article-title":"Bacterial populations of the small intestine in uremia","volume":"22","author":"Simenhoff","year":"1978","journal-title":"Nephron."},{"issue":"6","key":"B15-20250919","doi-asserted-by":"crossref","first-page":"F1211","DOI":"10.1152\/ajprenal.00298.2018","article-title":"Chronic kidney disease and the gut microbiome","volume":"316","author":"Hobby","year":"2019","journal-title":"Am J Physiol Renal Physiol."},{"issue":"1","key":"B16-20250919","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12882-019-1668-4","article-title":"High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients","volume":"21","author":"Hu","year":"2020","journal-title":"BMC Nephrol."},{"issue":"5","key":"B17-20250919","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3390\/jcm12051948","article-title":"Gut microbiota in chronic kidney disease: from composition to modulation towards better outcomes\u2014a systematic review","volume":"12","author":"Voroneanu","year":"2023","journal-title":"J Clin Med."},{"issue":"1","key":"B18-20250919","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13059-023-03056-y","article-title":"Metagenome-wide analysis uncovers gut microbial signatures and implicates taxon-specific functions in end-stage renal disease","volume":"24","author":"Zhang","year":"2023","journal-title":"Genome Biol."},{"issue":"8","key":"B19-20250919","doi-asserted-by":"crossref","first-page":"e18991","DOI":"10.1016\/j.heliyon.2023.e18991","article-title":"Chronic kidney disease and gut microbiota","volume":"9","author":"Amini Khiabani","year":"2023","journal-title":"Heliyon."},{"issue":"12","key":"B20-20250919","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","article-title":"Original research: aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents","volume":"69","author":"Wang","year":"2020","journal-title":"Gut."},{"issue":"1","key":"B21-20250919","doi-asserted-by":"crossref","first-page":"sfad303","DOI":"10.1093\/ckj\/sfad303","article-title":"Gut-immune axis and cardiovascular risk in chronic kidney disease","volume":"17","author":"Behrens","year":"2024","journal-title":"Clin Kidney J."},{"issue":"1","key":"B22-20250919","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41467-019-14177-z","article-title":"Impact of commonly used drugs on the composition and metabolic function of the gut microbiota","volume":"11","author":"Vich Vila","year":"2020","journal-title":"Nat Commun."},{"issue":"1","key":"B23-20250919","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/metabo14010078","article-title":"The kidney\u2013gut Axis as a novel target for nutritional intervention to counteract chronic kidney disease progression","volume":"14","author":"Caba\u0142a","year":"2024","journal-title":"Metabolites."},{"key":"B24-20250919","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3389\/fmicb.2018.00890","article-title":"Shifts on gut microbiota associated to mediterranean diet adherence and specific dietary intakes on general adult population","volume":"9","author":"Garcia-Mantrana","year":"2018","journal-title":"Front Microbiol."},{"issue":"2","key":"B25-20250919","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/09637486.2023.2294685","article-title":"Comparison of the low-calorie DASH diet and a low-calorie diet on serum TMAO concentrations and gut microbiota composition of adults with overweight\/obesity: a randomized control trial","volume":"75","author":"Diao","year":"2024","journal-title":"Int J Food Sci Nutr."},{"issue":"1","key":"B26-20250919","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1039\/c0fo00032a","article-title":"Mediterranean diet improves dyslipidemia and biomarkers in chronic renal failure patients","volume":"1","author":"Mekki","year":"2010","journal-title":"Food Funct."},{"issue":"10","key":"B27-20250919","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1111\/ajt.14707","article-title":"Dietary Approach to Stop Hypertension (DASH) diet and risk of renal function decline and all-cause mortality in renal transplant recipients","volume":"18","author":"Ost\u00e9","year":"2018","journal-title":"Am J Transplant."},{"issue":"1","key":"B28-20250919","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41387-024-00285-3","article-title":"Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trial","volume":"14","author":"Podadera-Herreros","year":"2024","journal-title":"Nutr Diabetes."},{"issue":"1","key":"B29-20250919","first-page":"1","article-title":"High-protein diet is bad for kidney health: unleashing the taboo","volume":"35","author":"Kalantar-Zadeh","year":"2020","journal-title":"Nephrol Dial Transplant."},{"issue":"16","key":"B30-20250919","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.3390\/nu15163503","article-title":"The microbiome and protein carbamylation: potential targets for protein-restricted diets supplemented with ketoanalogues in predialysis chronic kidney disease","volume":"15","author":"Faerber","year":"2023","journal-title":"Nutrients."},{"issue":"18","key":"B31-20250919","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1056\/NEJMra1700312","article-title":"Nutritional management of chronic kidney disease","volume":"377","author":"Kalantar-Zadeh","year":"2017","journal-title":"New Engl J Med."},{"issue":"2","key":"B32-20250919","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/toxins15020116","article-title":"Food-derived uremic toxins in chronic kidney disease","volume":"15","author":"Lauriola","year":"2023","journal-title":"Toxins (Basel)."},{"issue":"3 suppl 1","key":"B33-20250919","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","article-title":"KDOQI clinical practice guideline for nutrition in CKD: 2020 update","volume":"76","author":"Ikizler","year":"2020","journal-title":"Am J Kidney Dis."},{"key":"B34-20250919","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.clnesp.2021.08.037","article-title":"The association between low protein diet and body composition, muscle function, inflammation, and amino acid-based metabolic profile in chronic kidney disease stage 3\u20135 patients","volume":"46","author":"Hsu","year":"2021","journal-title":"Clin Nutr ESPEN."},{"issue":"16","key":"B35-20250919","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.7150\/ijms.66451","article-title":"Effects of low protein diet on modulating gut microbiota in patients with chronic kidney disease: a systematic review and meta-analysis of international studies","volume":"18","author":"Hsu","year":"2021","journal-title":"Int J Med Sci."},{"issue":"3","key":"B36-20250919","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/j.jrn.2017.11.007","article-title":"Does low-protein diet influence the uremic toxin serum levels from the gut microbiota in nondialysis chronic kidney disease patients?","volume":"28","author":"Black","year":"2018","journal-title":"J Ren Nutr."},{"issue":"9","key":"B37-20250919","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3390\/jcm8091424","article-title":"Nutritional therapy modulates intestinal microbiota and reduces serum levels of total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease (Medika study)","volume":"8","author":"Di Iorio","year":"2019","journal-title":"J Clin Med."},{"issue":"2","key":"B38-20250919","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3390\/nu13020636","article-title":"Gut microbiota bacterial species associated with mediterranean diet-related food groups in a northern Spanish population","volume":"13","author":"Ros\u00e9s","year":"2021","journal-title":"Nutrients."},{"issue":"Pt B","key":"B39-20250919","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.physbeh.2015.06.024","article-title":"Metabolic effects of non-nutritive sweeteners","volume":"152","author":"Pepino","year":"2015","journal-title":"Physiol Behav."},{"issue":"Pt B","key":"B40-20250919","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.physbeh.2016.03.014","article-title":"Low calorie sweeteners and gut microbiota","volume":"164","author":"Daly","year":"2016","journal-title":"Physiol Behav."},{"issue":"Pt A","key":"B41-20250919","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.fct.2017.06.046","article-title":"Sweeteners as food additives in the XXI century: a review of what is known, and what is to come","volume":"107","author":"Carocho","year":"2017","journal-title":"Food Chem Toxicol."},{"issue":"7","key":"B42-20250919","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1007\/s00394-019-02161-8","article-title":"The impact of food additives, artificial sweeteners and domestic hygiene products on the human gut microbiome and its fibre fermentation capacity","volume":"59","author":"Gerasimidis","year":"2020","journal-title":"Eur J Nutr."},{"issue":"18","key":"B43-20250919","doi-asserted-by":"crossref","first-page":"9863","DOI":"10.3390\/ijms22189863","article-title":"Inhibitory effects of artificial sweeteners on bacterial quorum sensing","volume":"22","author":"Markus","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"5","key":"B44-20250919","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3390\/nu12051348","article-title":"High intake of sugar and the balance between pro-and anti-inflammatory gut bacteria","volume":"12","author":"Satokari","year":"2020","journal-title":"Nutrients."},{"issue":"6","key":"B45-20250919","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3390\/nu10060761","article-title":"High-glucose or-fructose diet cause changes of the gut microbiota and metabolic disorders in mice without body weight change","volume":"10","author":"Do","year":"2018","journal-title":"Nutrients."},{"issue":"1","key":"B46-20250919","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1073\/pnas.1813780115","article-title":"Dietary sugar silences a colonization factor in a mammalian gut symbiont","volume":"116","author":"Townsend","year":"2019","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"B47-20250919","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2036.2006.03186.x","article-title":"Review article: fructose malabsorption and the bigger picture","volume":"25","author":"Gibson","year":"2007","journal-title":"Aliment Pharmacol Ther."},{"issue":"1","key":"B48-20250919","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1743-7075-9-89","article-title":"Fructose metabolism in humans - what isotopic tracer studies tell us","volume":"9","author":"Sun","year":"2012","journal-title":"Nutr Metab (Lond)."},{"key":"B49-20250919","doi-asserted-by":"crossref","first-page":"583608","DOI":"10.3389\/fnut.2020.583608","article-title":"Microbiota features associated with a high-fat\/low-fiber diet in healthy adults","volume":"7","author":"Bail\u00e9n","year":"2020","journal-title":"Front Nutr."},{"issue":"8","key":"B50-20250919","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/gutjnl-2018-317609","article-title":"Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial","volume":"68","author":"Wan","year":"2019","journal-title":"Gut."},{"issue":"1","key":"B51-20250919","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1038\/s41467-023-41074-3","article-title":"The interplay between dietary fatty acids and gut microbiota influences host metabolism and hepatic steatosis","volume":"14","author":"Schoeler","year":"2023","journal-title":"Nat Commun."},{"issue":"1","key":"B52-20250919","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12944-022-01702-1","article-title":"Replacing saturated fatty acids with polyunsaturated fatty acids increases the abundance of Lachnospiraceae and is associated with reduced total cholesterol levels\u2014a randomized controlled trial in healthy individuals","volume":"21","author":"Telle-Hansen","year":"2022","journal-title":"Lipids Health Dis."},{"issue":"8","key":"B53-20250919","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1039\/D1FO04254H","article-title":"Insights into gut microbiota metabolism of dietary lipids: the case of linoleic acid","volume":"13","author":"Huyan","year":"2022","journal-title":"Food Funct."},{"issue":"4","key":"B54-20250919","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbrc.2009.08.048","article-title":"The conjugated linoleic acid isomer trans-9,trans-11 is a dietary occurring agonist of liver X receptor alpha","volume":"388","author":"Ecker","year":"2009","journal-title":"Biochem Biophys Res Commun."},{"issue":"8","key":"B55-20250919","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1194\/jlr.M300120-JLR200","article-title":"Trans10, cis12-conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPARgamma modulator","volume":"44","author":"Granlund","year":"2003","journal-title":"J Lipid Res."},{"issue":"2","key":"B56-20250919","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.clnu.2019.02.037","article-title":"Unconjugated and secondary bile acid profiles in response to higher-fat, lower-carbohydrate diet and associated with related gut microbiota: a 6-month randomized controlled-feeding trial","volume":"39","author":"Wan","year":"2020","journal-title":"Clin Nutr."},{"issue":"2","key":"B57-20250919","doi-asserted-by":"crossref","first-page":"160","DOI":"10.12997\/jla.2021.10.2.160","article-title":"Iron reshapes the gut microbiome and host metabolism","volume":"10","author":"Botta","year":"2021","journal-title":"J Lipid Atheroscler."},{"key":"B58-20250919","first-page":"1","article-title":"A review of the effect of iron supplementation on the gut microbiota of children in developing countries and the impact of prebiotics","author":"Iddrisu","year":"2024","journal-title":"Nutr Res Rev."},{"issue":"suppl 1","key":"B59-20250919","first-page":"S28","article-title":"Oral iron supplementation: potential implications for the gut microbiome and metabolome in patients with CKD","volume":"21","author":"Kortman","year":"2017","journal-title":"Hemodial Int."},{"issue":"6","key":"B60-20250919","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3945\/ajcn.110.004564","article-title":"The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d'Ivoire","volume":"92","author":"Zimmermann","year":"2010","journal-title":"Am J Clin Nutr."},{"issue":"3","key":"B61-20250919","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1124\/jpet.118.251389","article-title":"The phosphate binder ferric citrate alters the gut microbiome in rats with chronic kidney disease","volume":"367","author":"Lau","year":"2018","journal-title":"J Pharmacol Exp Ther."},{"issue":"1","key":"B62-20250919","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ncp.10662","article-title":"Oral iron supplementation in patients with chronic kidney disease: can it be harmful to the gut microbiota?","volume":"37","author":"Ribeiro","year":"2022","journal-title":"Nutr Clin Pract."},{"key":"B63-20250919","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nutres.2021.09.001","article-title":"Vitamins, the gut microbiome and gastrointestinal health in humans","volume":"95","author":"Pham","year":"2021","journal-title":"Nutr Res."},{"key":"B64-20250919","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1515\/med-2020-0004","article-title":"Vitamin E for prevention of biofilm-caused Healthcare-associated infections","volume":"15","author":"Vergalito","year":"2020","journal-title":"Open Med (Wars)."},{"issue":"9","key":"B65-20250919","doi-asserted-by":"crossref","first-page":"e0163747","DOI":"10.1371\/journal.pone.0163747","article-title":"Effect of vitamin A on listeria monocytogenes infection in a silkworm model","volume":"11","author":"Castillo","year":"2016","journal-title":"PLoS One."},{"issue":"17","key":"B66-20250919","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1055\/s-0032-1315388","article-title":"Vitamin C inhibits staphylococcus aureus growth and enhances the inhibitory effect of quercetin on growth of escherichia coli in vitro","volume":"78","author":"Kallio","year":"2012","journal-title":"Planta Med."},{"key":"B67-20250919","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fgene.2015.00148","article-title":"Systematic genome assessment of B-vitamin biosynthesis suggests cooperation among gut microbes","volume":"6","author":"Magn\u00fasd\u00f3ttir","year":"2015","journal-title":"Front Genet."},{"issue":"3","key":"B68-20250919","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7762\/cnr.2021.10.3.181","article-title":"Vitamin D and the gut microbiota: a narrative literature review","volume":"10","author":"Tangestani","year":"2021","journal-title":"Clin Nutr Res."},{"issue":"12","key":"B69-20250919","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.3390\/nu15122727","article-title":"Vitamin K and hallmarks of ageing: focus on diet and gut microbiome","volume":"15","author":"Dai","year":"2023","journal-title":"Nutrients."},{"issue":"42","key":"B70-20250919","doi-asserted-by":"crossref","first-page":"E4485","DOI":"10.1073\/pnas.1415174111","article-title":"Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity","volume":"111","author":"Leclercq","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"10","key":"B71-20250919","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/j.1530-0277.2009.01022.x","article-title":"Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats","volume":"33","author":"Mutlu","year":"2009","journal-title":"Alcohol Clin Exp Res."},{"issue":"2","key":"B72-20250919","first-page":"223","article-title":"The gastrointestinal microbiome: alcohol effects on the composition of intestinal microbiota","volume":"37","author":"Engen","year":"2015","journal-title":"Alcohol Res."},{"issue":"1","key":"B73-20250919","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s40168-017-0359-2","article-title":"Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease","volume":"5","author":"Dubinkina","year":"2017","journal-title":"Microbiome."},{"issue":"8","key":"B74-20250919","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/jgh.16199","article-title":"Alcohol, the gut microbiome, and liver disease","volume":"38","author":"Jew","year":"2023","journal-title":"J Gastroenterol Hepatol."},{"issue":"4","key":"B75-20250919","first-page":"322","article-title":"Multi-strain probiotics: synergy among isolates enhances biological activities","volume":"10","author":"Kwoji","year":"2021","journal-title":"Biology (Basel)."},{"issue":"19","key":"B76-20250919","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.3390\/nu14194044","article-title":"The potential benefits and controversies of probiotics use in patients at different stages of chronic kidney disease","volume":"14","author":"Tian","year":"2022","journal-title":"Nutrients."},{"issue":"8","key":"B77-20250919","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B78-20250919","doi-asserted-by":"crossref","first-page":"689456","DOI":"10.3389\/fnut.2021.689456","article-title":"Polyphenol-mediated gut microbiota modulation: toward prebiotics and further","volume":"8","author":"Rodr\u00edguez-Daza","year":"2021","journal-title":"Front Nutr."},{"issue":"11","key":"B79-20250919","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","article-title":"The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics","volume":"17","author":"Swanson","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"10","key":"B80-20250919","first-page":"CD013631","article-title":"Synbiotics, prebiotics and probiotics for people with chronic kidney disease","volume":"10","author":"Cooper","year":"2023","journal-title":"Cochrane Database Syst Rev."},{"issue":"4","key":"B81-20250919","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3233\/NHA-170030","article-title":"Gut microbiome and aging: physiological and mechanistic insights","volume":"4","author":"Nagpal","year":"2018","journal-title":"Nutr Healthy Aging."},{"key":"B82-20250919","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jff.2018.05.018","article-title":"Effects of probiotic supplementation on inflammatory biomarkers and uremic toxins in non-dialysis chronic kidney patients: a double-blind, randomized, placebo-controlled trial","volume":"46","author":"de Faria Barros","year":"2018","journal-title":"J Funct Foods."},{"issue":"1","key":"B83-20250919","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.jrn.2017.06.010","article-title":"Probiotic supplementation in chronic kidney disease: a double-blind, randomized, placebo-controlled trial","volume":"28","author":"Borges","year":"2018","journal-title":"J Ren Nutr."},{"issue":"8","key":"B84-20250919","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3390\/nu14081637","article-title":"Probiotics-supplemented low-protein diet for microbiota modulation in patients with advanced chronic kidney disease (ProLowCKD): results from a placebo-controlled randomized trial","volume":"14","author":"De Mauri","year":"2022","journal-title":"Nutrients."},{"issue":"8","key":"B85-20250919","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1007\/s00394-020-02207-2","article-title":"Effect of probiotics on the intestinal microbiota of hemodialysis patients: a randomized trial","volume":"59","author":"Liu","year":"2020","journal-title":"Eur J Nutr."},{"issue":"2","key":"B86-20250919","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3390\/ijms25021132","article-title":"Modulation of miR-29a and miR-29b expression and their target genes related to inflammation and renal fibrosis by an oral nutritional supplement with probiotics in malnourished hemodialysis patients","volume":"25","author":"Sasso","year":"2024","journal-title":"Int J Mol Sci."},{"issue":"2","key":"B87-20250919","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/nu13020646","article-title":"Effect of unripe banana flour on gut-derived uremic toxins in individuals undergoing peritoneal dialysis: a randomized, double-blind, placebo-controlled, crossover trial","volume":"13","author":"de Andrade","year":"2021","journal-title":"Nutrients."},{"issue":"4","key":"B88-20250919","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3390\/nu14040805","article-title":"The effect of \u00df-glucan prebiotic on kidney function, uremic toxins and gut microbiome in stage 3 to 5 chronic kidney disease (CKD) predialysis participants: a randomized controlled trial","volume":"14","author":"Ebrahim","year":"2022","journal-title":"Nutrients."},{"issue":"12","key":"B89-20250919","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1039\/C8FO01876F","article-title":"Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial","volume":"9","author":"Esgalhado","year":"2018","journal-title":"Food Funct."},{"issue":"19","key":"B90-20250919","doi-asserted-by":"crossref","first-page":"e2100374","DOI":"10.1002\/mnfr.202100374","article-title":"The impact of enriched resistant starch type-2 cookies on the gut microbiome in hemodialysis patients: a randomized controlled trial","volume":"65","author":"Kemp","year":"2021","journal-title":"Mol Nutr Food Res."},{"issue":"3","key":"B91-20250919","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ekir.2023.12.017","article-title":"Targeting gut microbiome with prebiotic in patients with CKD: the TarGut-CKD study","volume":"9","author":"Sohn","year":"2024","journal-title":"Kidney Int Rep."},{"issue":"5","key":"B92-20250919","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/toxins13050334","article-title":"An innovative synbiotic formulation decreases free serum indoxyl sulfate, small intestine permeability and ameliorates gastrointestinal symptoms in a randomized pilot trial in stage IIIb-IV CKD patients","volume":"13","author":"Cosola","year":"2021","journal-title":"Toxins (Basel)."},{"issue":"1","key":"B93-20250919","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12882-022-02890-9","article-title":"The effects of synbiotics on indoxyl sulphate level, constipation, and quality of life associated with constipation in chronic haemodialysis patients: a randomized controlled trial","volume":"23","author":"Lydia","year":"2022","journal-title":"BMC Nephrol."},{"issue":"12","key":"B94-20250919","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.3390\/nu13124481","article-title":"Synbiotics easing renal failure by improving gut microbiology ii (Synergy ii): a feasibility randomized controlled trial","volume":"13","author":"McFarlane","year":"2021","journal-title":"Nutrients."},{"issue":"18","key":"B95-20250919","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.3390\/nu14183804","article-title":"Enzobiotics\u2014a novel therapy for the elimination of uremic toxins in patients with CKD (EETOX study): a multicenter double-blind randomized controlled trial","volume":"14","author":"Saxena","year":"2022","journal-title":"Nutrients."},{"issue":"3","key":"B96-20250919","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3390\/nu11030496","article-title":"Dietary components that may influence the disturbed gut microbiota in chronic kidney disease","volume":"11","author":"Mafra","year":"2019","journal-title":"Nutrients."},{"issue":"17","key":"B97-20250919","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.3390\/molecules28176403","article-title":"Plant polyphenols and their potential benefits on cardiovascular health: a review","volume":"28","author":"Iqbal","year":"2023","journal-title":"Molecules."},{"issue":"1","key":"B98-20250919","doi-asserted-by":"crossref","first-page":"293","DOI":"10.22271\/journalofsport.2021.v6.i1e.2236","article-title":"Classifications of polyphenols and their potential application in human health and diseases","volume":"6","author":"Prabhu","year":"2021","journal-title":"Int J Physiol Nutr Phys Educ."},{"key":"B99-20250919","doi-asserted-by":"crossref","first-page":"850902","DOI":"10.1155\/2015\/850902","article-title":"A survey of modulation of gut microbiota by dietary polyphenols","volume":"2015","author":"Due\u00f1as","year":"2015","journal-title":"Biomed Res Int."},{"issue":"2","key":"B100-20250919","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/nutrit\/nuad048","article-title":"Blueberry, cranberry, raspberry, and strawberry as modulators of the gut microbiota: target for treatment of gut dysbiosis in chronic kidney disease? from current evidence to future possibilities","volume":"82","author":"Coutinho-Wolino","year":"2024","journal-title":"Nutr Rev."},{"issue":"2","key":"B101-20250919","first-page":"1472","article-title":"Garlic lowers blood pressure in hypertensive subjects, improves arterial stiffness and gut microbiota: a review and meta-analysis","volume":"19","author":"Ried","year":"2020","journal-title":"Exp Ther Med."},{"issue":"4","key":"B102-20250919","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.3390\/ijms24043084","article-title":"Effects of berries, phytochemicals, and probiotics on atherosclerosis through gut microbiota modification: a meta-analysis of animal studies","volume":"24","author":"Khalili","year":"2023","journal-title":"Int J Mol Sci."},{"issue":"1","key":"B103-20250919","doi-asserted-by":"crossref","first-page":"2392875","DOI":"10.1080\/19490976.2024.2392875","article-title":"Examination of sex-specific interactions between gut microbiota and host metabolism after 12-week combined polyphenol supplementation in individuals with overweight or obesity","volume":"16","author":"Jardon","year":"2024","journal-title":"Gut Microbes."},{"issue":"14","key":"B104-20250919","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.3390\/nu14142921","article-title":"Litchi-derived polyphenol alleviates liver steatosis and gut dysbiosis in patients with non-alcoholic fatty liver disease: a randomized double-blinded, placebo-controlled study","volume":"14","author":"Jinato","year":"2022","journal-title":"Nutrients."},{"issue":"9","key":"B105-20250919","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.3390\/nu12092800","article-title":"Whole blueberry and isolated polyphenol-rich fractions modulate specific gut microbes in an in vitro colon model and in a pilot study in human consumers","volume":"12","author":"Ntemiri","year":"2020","journal-title":"Nutrients."},{"issue":"10","key":"B106-20250919","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1016\/j.clnu.2021.08.027","article-title":"Crosstalk among intestinal barrier, gut microbiota and serum metabolome after a polyphenol-rich diet in older subjects with \u201cleaky gut\u201d: the MaPLE trial","volume":"40","author":"Peron","year":"2021","journal-title":"Clin Nutr."},{"issue":"11","key":"B107-20250919","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1093\/jn\/nxac201","article-title":"Herbs and spices modulate gut bacterial composition in adults at risk for CVD: results of a prespecified exploratory analysis from a randomized, crossover, controlled-feeding study","volume":"152","author":"Petersen","year":"2022","journal-title":"J Nutr."},{"issue":"6","key":"B108-20250919","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ajcnut.2023.03.017","article-title":"Wild blueberry (poly)phenols can improve vascular function and cognitive performance in healthy older individuals: a double-blind randomized controlled trial","volume":"117","author":"Wood","year":"2023","journal-title":"Am J Clin Nutr."},{"issue":"6","key":"B109-20250919","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1053\/j.jrn.2022.01.010","article-title":"Can resveratrol supplementation reduce uremic toxin plasma levels from the gut microbiota in nondialyzed patients with chronic kidney disease?","volume":"32","author":"Alvarenga","year":"2022","journal-title":"J Ren Nutr."},{"issue":"1","key":"B110-20250919","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/nu14010231","article-title":"Curcumin supplementation (Meriva\u00ae) modulates inflammation, lipid peroxidation and gut microbiota composition in chronic kidney disease","volume":"14","author":"Pivari","year":"2022","journal-title":"Nutrients."},{"issue":"6","key":"B111-20250919","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s11255-020-02760-z","article-title":"Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study","volume":"53","author":"Salarolli","year":"2021","journal-title":"Int Urol Nephrol."},{"key":"B112-20250919","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clnesp.2021.11.012","article-title":"Effect of cranberry supplementation on toxins produced by the gut microbiota in chronic kidney disease patients: a pilot randomized placebo-controlled trial","volume":"47","author":"Teixeira","year":"2022","journal-title":"Clin Nutr ESPEN."},{"issue":"1","key":"B113-20250919","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/gutjnl-2022-328166","article-title":"Advancing human gut microbiota research by considering gut transit time","volume":"72","author":"Proch\u00e1zkov\u00e1","year":"2023","journal-title":"Gut."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:36:54Z","timestamp":1786369014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":113,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000000705","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]}}}